Management of Bell's Palsy in Children
Oral corticosteroids may be considered for children with Bell's palsy within 72 hours of symptom onset, though the evidence in pediatrics is limited and children generally have excellent spontaneous recovery rates. The decision should involve shared decision-making with caregivers, as the benefit in children remains uncertain despite extrapolation from adult data 1.
Key Management Principles
Initial Assessment
First, confirm the diagnosis by excluding other causes of facial paralysis through history and physical examination. Look specifically for:
- Bilateral involvement (rare in Bell's palsy)
- Other cranial nerve deficits
- History of trauma, tumor, or tick exposure
- Signs of Ramsay Hunt syndrome (vesicles in ear canal)
- Incomplete paralysis of isolated facial nerve branches
- Systemic illness suggesting Lyme disease or sarcoidosis
Do not obtain routine laboratory testing or imaging unless atypical features are present 1, 2.
Corticosteroid Therapy: The Evidence Gap
The 2013 AAO-HNS guidelines acknowledge a critical limitation: there are no controlled trials supporting steroid use specifically in children 1. Two systematic reviews (Pitaro and Daniel; Salman and MacGregor) found no firm evidence for routine steroid use in pediatric Bell's palsy 1.
However, a 2025 meta-analysis of 750 children showed that corticosteroid monotherapy was associated with higher complete recovery rates beyond 1 month and lower risk of incomplete recovery after 6 months 3. This represents the most recent and highest-quality pediatric-specific evidence available.
Treatment Algorithm
If treating within 72 hours of onset:
- Prednisolone 1 mg/kg/day (maximum 60 mg) for 5 days, then taper over 5 days, OR
- Prednisolone 50 mg daily for 10 days (for older/larger children)
The benefit after 72 hours is unclear 1.
Important context: Children have higher spontaneous recovery rates than adults (often >90% complete recovery without treatment) 1, 4. The decision to treat must weigh this favorable natural history against the generally low risk of short-term corticosteroids.
What NOT to Do
Do not prescribe antiviral therapy alone - this has no benefit over placebo 1, 2.
Combination therapy (steroids + antivirals) is optional and has equilibrium of benefit and harm even in adults 1. Given the lack of pediatric evidence and excellent prognosis in children, combination therapy is generally not warranted unless there are specific concerns for herpes zoster involvement.
Essential Eye Protection
Implement eye protection immediately for any child with impaired eye closure 2. This is a strong recommendation regardless of other treatment decisions. Provide:
- Artificial tears during the day
- Lubricating ointment at night
- Eye patching or taping if needed
- Instructions to parents about corneal injury risk
Follow-Up and Red Flags
Reassess or refer to a facial nerve specialist if:
- New or worsening neurologic findings develop at any point
- Ocular symptoms emerge
- Incomplete recovery at 3 months 1, 2
- Recurrence (occurs in approximately 20% of pediatric cases) 5
Clinical Pitfalls to Avoid
Don't assume all facial weakness is Bell's palsy - bilateral involvement, other cranial nerve signs, or atypical features warrant imaging (MRI with contrast of the entire facial nerve course) 1
Don't routinely order Lyme serology unless there is epidemiologic risk or clinical suspicion - this practice increased inappropriately after guideline publication despite being discouraged 6
Don't delay eye protection while deciding about steroids - corneal injury can occur rapidly
Don't promise complete recovery - while most children recover fully, 4-6% may have persistent abnormal facial sensations or incomplete recovery 5
Practical Considerations
The 2025 meta-analysis 3 provides the strongest pediatric-specific evidence to date, suggesting benefit from corticosteroid monotherapy beyond the first month. However, this must be balanced against:
- The generally favorable prognosis without treatment (86-90% complete recovery) 4
- Lack of randomized controlled trials in children
- The need for caregiver involvement in decision-making 1
In practice, offering corticosteroids is reasonable for children presenting within 72 hours, particularly those with complete paralysis or significant functional impairment, while acknowledging the evidence limitations to families.